June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Analysis of 1-month-old MOTS-c in H2O; Using High Resolution Mass Spectrometry
Author Affiliations & Notes
  • Zahra Mohtashami
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Mustafa Ozgul
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Ben Katz
    Chemistry, University of California Irvine, Irvine, California, United States
  • M.Cristina Kenney
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Zahra Mohtashami None; Mustafa Ozgul None; Ben Katz None; M.Cristina Kenney None
  • Footnotes
    Support  This work was supported by the Discovery Eye Foundation, Polly and Michael Smith, Iris and the B. Gerald Cantor Foundation, Beckman Initiative for Macular Research, National Institute on Aging [AG006168 to SMJ] and National Eye Institute R01 EY027363 (MCK). We acknowledge the support of the Institute for Clinical and Translational Science (ICTS) at University of California, Irvine. Supported in part by an Unrestricted Departmental Grant from Research to Prevent Blindness. We acknowledge the support of the Institute for Clinical and Translational Science (ICTS) at University of California, Irvine
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 474 – A0011. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zahra Mohtashami, Mustafa Ozgul, Ben Katz, M.Cristina Kenney; Analysis of 1-month-old MOTS-c in H2O; Using High Resolution Mass Spectrometry. Invest. Ophthalmol. Vis. Sci. 2022;63(7):474 – A0011.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : MOTS-c peptide is one of the mitochondrial derived peptides which represent a new class of biologically active molecules with potential to protect retinal cells from oxidative stress associated with retinal pathology. State-of-the-art techniques can be used to analyze stability of intact MOTS-c peptide and identify MOTS-c fragments for possible use in future therapeutic investigation of age-related macular degeneration.

Methods : Stability analyses was done by High-Resolution Mass Spectrometry (HRMS). During this process the MOTS-c solutions with a concentration of 12.5 μg/ml were stored at 4°C and 37°C for 30 days.
Mass spectrometric analysis was performed using Xevo G2-XS Quadrupole Time-of-Flight mass spectrometer (HRMS) coupled to UPLC. The UPLC method used 30 minutes linear gradient at 0.3 mL/min from 97% A to 97% B where A is 0.1% Formic Acid in water and B is 100% Acetonitrile. For HRMS analysis, positive electrospray ionization mode was utilized. A capillary transfer temperature of 300°C and a spray voltage of 3.0 kV were used to accomplish ionization. A resolution of 30,000 Full Width at Half Maximum was used for a full scan experiment within a range of 100–2000 m/z as well as 15,000 FWHM with an isolation window adjusted to 2.0 m/z for. Leucine Enkephalin was used as a lock mass for nominal mass correction, and a CsNaI ladder was used to calibrate the detector.

Results : In MOTS-c peptide with molecular weight of 2173.11g/mol, the main ions of +5, +4 and +3 were formed at 435.84, 544.54 and 725.72 m/z (Figure 1). In MOTS-c, oxidation of methionine remained constant upon incubation of MOTS-C in water for 30 days at 37oC. Intact MOTS-c peptides without oxidation were detected at the highest intensities. HRMS spectrums of MOTS-c stability in HPLC water are presented in Figures.

Conclusions : It is the first time that 1-month stability properties of MOTS-c peptide and its oxidation and degradation products have been analyzed in detail using advanced HRMS technologies. The data suggest that intact MOTS-c peptides in HPLC water represent a more stable form than Humanin-G peptides in water. The results may help researchers design better in vitro and in vivo experimental parameters to further understand the critical role of MOTS-c in physiological conditions and human diseases.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×